Skip to main content
. 2017 Dec 7;3(3):573–582. doi: 10.1016/j.ekir.2017.11.020

Table 3.

The association of urinary 8-oxodG and 8-oxoGuo with measured GFR change rates in mixed models: The Renal Iohexol Clearance Survey Follow-Up Study

Risk factora Model 1 unadjusted
Model 2 adjusted for sex, age, weight, and height
Model 3 fully adjustedb
Estimate (ml/min per 1.73 m2 per year) (95% CI) P Estimate (ml/min per 1.73 m2 per year) (95% CI) P Estimate (ml/min per 1.73 m2 per year) (95% CI) P
Urinary 8-oxodG
 Per 1 nmol/mmol −0.12 (−0.29 to 0.06) 0.19 −0.09 (−0.27 to 0.09) 0.35 −0.02 (−0.20 to 0.16) 0.82
 Quartile 1 0.00 (ref) 0.00 (ref) 0.00 (ref)
 Quartile 2 −0.12 (−0.42 to 0.18) −0.11 (−0.40 to 0.19) −0.08 (−0.37 to 0.21)
 Quartile 3 −0.16 (−0.46 to 0.13) −0.14 (−0.44 to 0.16) −0.09 (−0.39 to 0.21)
 Quartile 4 −0.24 (−0.54 to 0.05) −0.20 (−0.51 to 0.11) −0.08 (−0.38 to 0.23)
(0.45c) (0.64c) (0.88c)
 Q4 versus Q1–Q3d −0.15 (−0.39 to 0.09) 0.23 −0.11 (−0.36 to 0.14) 0.39 −0.02 (−0.26 to 0.23) 0.89
Urinary 8-oxoGuo
 Per 1 nmol/mmol −0.04 (−0.11 to 0.03) 0.28 −0.02 (−0.10 to 0.05) 0.52 0.0003 (−0.07 to 0.08) 0.99
 Quartile 1 0.00 (ref) 0.00 (ref) 0.00 (ref)
 Quartile 2 −0.09 (−0.39 to 0.20) −0.06 (−0.35 to 0.24) −0.02 (−0.32 to 0.27)
 Quartile 3 0.05 (−0.24 to 0.35) 0.10 (−0.19 to 0.40) 0.17 (−0.12 to 0.47)
 Quartile 4 −0.21 (−0.51 to 0.09) −0.15 (−0.45 to 0.15) −0.02 (−0.32 to 0.29)
(0.34c) (0.39c) (0.56c)
 Q4 versus Q1–Q3d −0.20 (−0.44 to 0.05) 0.12 −0.17 (−0.41 to 0.08) 0.18 −0.07 (−0.32 to 0.17) 0.56

CI, confidence interval; 8-oxodG, 8-oxo-7,8-dihydro-2′-deoxyguanosine; 8-oxoGuo, 8-oxo-7,8-dihydroguanosine.

a

8-oxodG and 8-oxoGuo were normalized for urinary creatinine.

b

Adjusted for sex, baseline age, height, body weight, diastolic blood pressure, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, fasting triglycerides, hemoglobin A1c, high-sensitivity C-reactive protein; a dichotomous variable for the weekly use of alcohol; number of cigarettes currently smoked; log urine albumin-to-creatinine ratio; and the use of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker.

c

Wald test for linear trend was applied.

d

Persons with 8-oxodG or 8-oxoGuo in the highest quartile compared with the lowest quartiles.